Athens Medical Centre (STU:ACS) Beta: 2.1953 (As of Jun. 25, 2026)


STU:ACS Athens Medical Centre SA STU:ACS
60 GF Score
Price €1.59
GF Value €1.93
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Beta?

Athens Medical Centre STU:ACS +0.63% 60 Beta is 2.1953 as of Jun. 25, 2026. GuruFocus rates STU:ACS with a GF Score™ of 60/100 and a GF Value™ of €1.93. The stock has 8 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Athens Medical Centre's Beta is 2.1953.


Athens Medical Centre  (STU:ACS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Athens Medical Centre Beta Related Terms


Athens Medical Centre Beta Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre Beta Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.52 0.85 -0.07 -0.05

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.72 -0.07 1.81 -0.05

STU:ACS vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Athens Medical Centre's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athens Medical Centre Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's Beta distribution charts can be found below:

* The bar in red indicates where Athens Medical Centre's Beta falls into.


STU:ACS
60GF Score
Athens Medical Centre SA STU:ACS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.1953 mean?
Athens Medical Centre (STU:ACS) has a Beta of 2.1953 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Athens Medical Centre and its competitors.
Is Athens Medical Centre's Beta too high?
Athens Medical Centre's current Beta is 2.1953. Overall, Athens Medical Centre has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Beta compare to HCA and THC?
Athens Medical Centre's Beta of 2.1953 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Athens Medical Centre and its competitors. Athens Medical Centre's current Beta is 2.1953. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Athens Medical Centre (STU:ACS) has a current Beta of 2.1953. The stock's GF Value™ is €1.93, compared to a current price of €1.59 — trading 17.9% below its estimated fair value. The current Beta is 2.1953. Athens Medical Centre's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Athens Medical Centre (STU:ACS), the current Beta is 2.1953 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (STU:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.59 is trading 17.9% below its estimated GF Value™ of €1.93.

Key valuation signals for STU:ACS:

  • Beta: 2.1953
  • GF Value™: €1.93 vs. price of €1.59 (17.9% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the STU:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Athens Medical Centre Business Description

Other Exchanges IATR:GreeceACS:Germany
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
60GF Score

Get the complete analysis for STU:ACS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59
Price
€1.93
GF Value